Remove 2007 Remove Leadership Remove Pharmaceuticals Remove Technology
article thumbnail

How To Discover Your Organization’s Next Big Growth Opportunities

Tanveer Naseer

For example, they might say, “We’re a bank,” or “We make office furniture,” or “We’re in the pharmaceutical business.” In other words, Larry Page sees Google as a broad portfolio of science, technology, and Internet-related resources that can be leveraged into almost any meaningful new venture. This is quite understandable.

How To 100
article thumbnail

Performance Measurement

Strategy Driven

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). Copyright 2007-2011 by StrategyDriven, Inc. Consider leaving a comment!

ROIC 62
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Recommended Resources – An Interview with Paul Leinwand and Cesare Mainardi, authors of The Essential Advantage

Strategy Driven

Large downturns (such as this recession), technology disruptions, or regulatory shifts create discontinuities that simply accelerate the industry’s evolution toward this equilibrium state. Copyright 2007-2011 by StrategyDriven, Inc. The theoretical optimized industry is one with two or three players performing very different roles.

article thumbnail

The 2010 Execution Round-Up: Six Companies That Couldn't 'Get It.

Strategy Driven

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

article thumbnail

The Key to Change Is Middle Management

Harvard Business Review

I studied large-scale change and innovation efforts in 56 randomly selected companies in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. In 2007, he was handed the daunting task of fixing HP’s worldwide compensation structure for 20,000 sales employees.